Simon Lewin
Adherence to TB Medication
PLoS Med 4(7):e238. doi:10.1371/journal.pmed.0040238
SIMON LEWIN, London School of Hygiene and Tropical Medicine
A new systematic review has shown that we don’t understand well enough the reasons for poor adherence to tuberculosis medication. Simon Lewin of the London School of Hygiene and Tropical Medicine calls for a better approach in the area.
SIMON LEWIN, London School of Hygiene and Tropical Medicine
A new systematic review has shown that we don’t understand well enough the reasons for poor adherence to tuberculosis medication. Simon Lewin of the London School of Hygiene and Tropical Medicine calls for a better approach in the area.
Nancy Padian
David Mabey
Where Now for HIV Prevention Trials?
REFERENCE: The Lancet 2007; 370:251-261
NANCY PADIAN, University of California, San Francisco
COMMENT: DAVID MABEY, London School of Hygiene and Tropical Medicine
A major study testing a latex diaphragm for HIV prevention found no additional benefit. This adds to a growing number of HIV prevention trials that have failed to find a positive result. So what do we do now? Nancy Padian of the University of California, San Francisco, explains the trial’s results, while David Mabey of LSHTM suggests the field needs greater funding.
NANCY PADIAN, University of California, San Francisco
COMMENT: DAVID MABEY, London School of Hygiene and Tropical Medicine
A major study testing a latex diaphragm for HIV prevention found no additional benefit. This adds to a growing number of HIV prevention trials that have failed to find a positive result. So what do we do now? Nancy Padian of the University of California, San Francisco, explains the trial’s results, while David Mabey of LSHTM suggests the field needs greater funding.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
